Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide in Relapsed or Refractory HTLV-1 Associated Adult T Cell Leukemia/Lymphoma
NCT01274533Phase 2Completed
- Sponsor
- Columbia University
- Start
- Dec 2010
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in adult T-cell leukemia-lymphoma (ATLL), sponsored by Columbia University. Started Dec 2010; status: completed.
02
Drugs
lenalidomide
03
Conditions
adult T-cell leukemia-lymphoma (ATLL)
Beyond the preview
Go deeper on NCT01274533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01274533.